Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer.
作者： T M Pisansky , S S Cha , J D Earle , E D Durr , T F Kozelsky
DOI: 10.1200/JCO.1993.11.11.2158
关键词: Radiation therapy 、 Disease 、 Prostate 、 Prostate cancer 、 Antigen 、 Prostate-specific antigen 、 Pathology 、 Adenocarcinoma 、 Internal medicine 、 Medicine 、 Oncology 、 Stage (cooking)
摘要: PURPOSEThis study was conducted to determine the value of prostate-specific antigen (PSA) as a pretherapy prognostic factor for localized prostate cancer treated with primary irradiation (RT).PATIENTS AND METHODSBetween March 1987 and December 1990, 254 patients PSA determinations were clinical stage A2 C adenocarcinoma. In conjunction other factors, evaluated whether it had independent predictive disease outcome.RESULTSPretherapy highly directly correlated stage, tumor grade, acid phosphatase level. With median follow-up duration 24 months, 241 (95%) fully assessable outcome. these patients, grade sole factors relapse (ie, clinically determined and/or increasing level). The combination information defined groups distinctly different out...
sci-hub.se 参考文章(37)
Alan W. Partin, H. Ballentine Carter, Daniel W. Chan, Jonathan I. Epstein, Joseph E. Oesterling, Robert C. Rock, Jed P. Weber, Patrick C. Walsh, Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia Journal of Urology. ,vol. 143, pp. 747- 752 ,(1990) , 10.1016/S0022-5347(17)40079-6
Joseph E. Oesterling, Daniel W. Chan, Jonathan I. Epstein, Allyn W. Kimball, Debra J. Bruzek, Robert C. Rock, Charles B. Brendler, Patrick C. Walsh, Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy The Journal of Urology. ,vol. 139, pp. 766- 772 ,(1988) , 10.1016/S0022-5347(17)42630-9
Irving D. Kaplan, Richard S. Cox, Malcolm A. Bagshaw, Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: Followup Journal of Urology. ,vol. 149, pp. 519- 522 ,(1993) , 10.1016/S0022-5347(17)36133-5
Paul F. Schellhammer, Steven M. Schlossberg, Anas M. El-Mahdi, George L. Wright, Diane N. Brassil, PROSTATE SPECIFIC ANTIGEN LEVELS AFTER DEFINITIVE IRRADIATION FOR CARCINOMA OF THE PROSTATE The Journal of Urology. ,vol. 145, pp. 1008- 1010 ,(1991) , 10.1016/S0022-5347(17)38514-2
Michael K. Brawer, Michael P. Chetner, Jeanette Beatie, David M. Buchner, Robert L. Vessella, Paul H. Lange, Screening for Prostatic Carcinoma with Prostate Specific Antigen The Journal of Urology. ,vol. 147, pp. 841- 845 ,(1992) , 10.1016/S0022-5347(17)37401-3
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
David C. Utz, Pathologic Differentiation and Prognosis of Prostatic Carcinoma JAMA: The Journal of the American Medical Association. ,vol. 209, pp. 1701- 1703 ,(1969) , 10.1001/JAMA.1969.03160240057016
P. Kellokumpu-Lehtinen, M. Nurmi, P. Koskinen, K. Irjala, Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation. Urologia Internationalis. ,vol. 46, pp. 6- 8 ,(1991) , 10.1159/000281763
George S. Dundas, Arthur T. Porter, Peter M. Venner, Prostate-specific antigen: Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker Cancer. ,vol. 66, pp. 45- 48 ,(1990) , 10.1002/1097-0142(19900701)66:1<45::AID-CNCR2820660110>3.0.CO;2-G
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25